Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Oct 18, 2024

BUY
$191.89 - $259.92 $555,137 - $751,948
2,893 New
2,893 $583,000
Q1 2023

May 10, 2023

SELL
$191.89 - $259.92 $23,218 - $31,450
-121 Reduced 4.01%
2,893 $583,000
Q4 2022

Oct 18, 2024

SELL
$197.11 - $250.07 $7,490 - $9,502
-38 Reduced 1.25%
3,014 $656,000
Q4 2022

Feb 09, 2023

SELL
$197.11 - $250.07 $7,490 - $9,502
-38 Reduced 1.25%
3,014 $656,000
Q3 2022

Oct 18, 2024

BUY
$182.44 - $250.54 $556,806 - $764,648
3,052 New
3,052 $600,000
Q3 2022

Nov 10, 2022

SELL
$182.44 - $250.54 $103,261 - $141,805
-566 Reduced 15.64%
3,052 $601,000
Q2 2022

Aug 10, 2022

BUY
$204.13 - $302.4 $738,542 - $1.09 Million
3,618 New
3,618 $774,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.49B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.